Grizzly Research is short XP Inc. (XP), saying its “research uncovers that the company is running a massive Ponzi scheme facilitated through ...

Adds XP comment XP Inc. (NASDAQ:XP) fell 3% after a short report from Grizzly Research on the Brazilian fintech company.

Xp Inc. (XP) tells Reuters that the company is “aware of recently disclosed unfounded allegations” after Grizzly Research revealed a short ...

XP retreated for a third day on Wednesday, losing 5.48 percent to end at $14.14 each as investors sold off positions ...

Grizzly Research anticipates that Medicare, Medicaid, and other health insurers will seek to recover overpayments made to GeneDx due to the illegal code stacking practices. The firm's research ...

Grizzly Research’s report alleges that XP Inc. is engaging in a Ponzi scheme through the sale of Certificado de Operações Estruturadas (COE), which are presented as proprietary trading profits but are ...

including by the California Grizzly Research Network, a University of California research group that undertook a thorough study of the past, present, and future of grizzlies in the state. Along with ...

According to U.S.-based Grizzly Research LLC, many of the company’s European solar projects appear not to exist. Renesola has said it will review the report and address the key inaccuracies with ...

Research shows that large carnivores, such as grizzly bears and wolves, are moving further away from trails with lots of ...

Investing.com -- Grizzly Research has shorted GeneDx, a genetic testing company, accusing them of widespread fraud. GeneDx specializes in advanced genomic testing, with a focus on rare and ultra ...

Investing.com -- Grizzly Research has shorted GeneDx, a genetic testing company, accusing them of widespread fraud. GeneDx specializes in advanced genomic testing, with a focus on rare and ultra-rare ...